Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
4.720
-0.540 (-10.27%)
At close: Sep 18, 2026, 4:00 PM EDT
4.660
-0.060 (-1.27%)
After-hours: Sep 18, 2026, 7:49 PM EDT
Niki BioSolutions Employees
Niki BioSolutions had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,247,494
Market Cap
13.87M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -2 | -66.67% | 1 | 0 |
| Dec 31, 2023 | 3 | -16 | -84.21% | 3 | 0 |
| Dec 31, 2022 | 19 | -7 | -26.92% | 18 | 1 |
| Dec 31, 2021 | 26 | 0 | - | 26 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Enlivex | 34 |
| Lisata Therapeutics | 21 |
| SeaStar Medical Holding | 18 |
| Moleculin Biotech | 17 |
| CalciMedica | 15 |
| Quoin Pharmaceuticals | 6 |
| Adial Pharmaceuticals | 5 |
NIKI News
- 5 days ago - Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics - GlobeNewsWire
- 11 days ago - Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - GlobeNewsWire
- 22 days ago - Niki BioSolutions files $75M mixed securities shelf - TheFly
- 2 months ago - Aptorum Group Provides Update on DiamiR Biosciences Merger - GlobeNewsWire
- 2 months ago - Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference - GlobeNewsWire
- 2 months ago - Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - GlobeNewsWire
- 3 months ago - Statement in Response to Silver Elephant's News Release Dated June 17, 2026 - Newsfile Corp
- 3 months ago - Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - GlobeNewsWire